Last updated: 5 May 2021 at 8:18pm EST

Vijay Tammara Net Worth




The estimated Net Worth of Vijay Tammara is at least $2.84 mil dollars as of 4 May 2021. Mr. Tammara owns over 15,711 units of Ocugen Inc stock worth over $2,843 and over the last 5 years he sold OCGN stock worth over $0. In addition, he makes $0 as Senior Vice President - Regulatory and Quality at Ocugen Inc.

Mr. Tammara OCGN stock SEC Form 4 insiders trading

Vijay has made over 2 trades of the Ocugen Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 15,711 units of OCGN stock worth $12,726 on 4 May 2021.

The largest trade he's ever made was exercising 34,308 units of Ocugen Inc stock on 29 April 2021 worth over $24,359. On average, Vijay trades about 8,337 units every 1 days since 2020. As of 4 May 2021 he still owns at least 2,311 units of Ocugen Inc stock.

You can see the complete history of Mr. Tammara stock trades at the bottom of the page.





Vijay Tammara biography

Vijay Tammara Ph.D. serves as Senior Vice President - Regulatory and Quality of the Company. He has served as our Senior Vice President, Regulatory & Quality since December 2019 and previously served as our Vice President, Regulatory & Quality from September 2019 to December 2019. Dr. Tammara has served as Vice President, Regulatory & Quality of OpCo, our wholly owned subsidiary, since August 2017. Prior to joining OpCo, Dr. Tammara worked at VRT Pharma Consulting LLC, a business consulting company, as CEO and President from July 2014 to August 2017. Dr. Tammara previously served as VP Regulatory Affairs at Nuron Biotech Inc. from September 2010 to August 2013, Director of Regulatory Affairs at Merck & Co., Inc. from March 2004 to September 2010, Senior Associate Director at Wyeth Pharmaceuticals from September 2002 to March 2004, and Assistant Director at Sanofi-Synthelabo in Worldwide Regulatory Affairs from March 2000 to September 2000. Dr. Tammara received his Bachelor of Pharmacy from Kakatiya University, Master’s in Pharmacy from Nagpur University, and Ph.D. in Pharmaceutics from the University of Louisiana, Monroe, LA.



How old is Vijay Tammara?

Vijay Tammara is 60, he's been the Senior Vice President - Regulatory and Quality of Ocugen Inc since 2019. There are 4 older and 12 younger executives at Ocugen Inc. The oldest executive at Ocugen Inc is Prabhavathi Fernandes, 71, who is the Independent Director.

What's Vijay Tammara's mailing address?

Vijay's mailing address filed with the SEC is C/O OCUGEN, INC., 263 GREAT VALLEY PARKWAY, MALVERN, PA, 19355.

Insiders trading at Ocugen Inc

Over the last 5 years, insiders at Ocugen Inc have traded over $18,069,176 worth of Ocugen Inc stock and bought 1,511,356 units worth $684,830 . The most active insiders traders include Shankar Musunuri, Junge Zhang y Uday Kompella. On average, Ocugen Inc executives and independent directors trade stock every 21 days with the average trade being worth of $96,347. The most recent stock trade was executed by Junge Zhang on 14 June 2023, trading 200,278 units of OCGN stock currently worth $100,139.



What does Ocugen Inc do?

ocugen, inc., is a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular disorders. the company’s lead programs in ocular graft versus host disease (ocu300) and chronic dry eye disease (ocu310) are expected to enter pivotal clinical trials in 2018. ocu300 received the first and only orphan drug designation for ocular graft versus host disease, providing certain regulatory and economic benefits. ocugen is also developing novel biologic therapies for retinitis pigmentosa (ocu100) and wet amd (ocu200), as well as a groundbreaking modifier gene therapy platform with potential to address a broad spectrum of inherited retinal disorders (ocu400). for more information, please visit www.ocugen.com.



What does Ocugen Inc's logo look like?

Ocugen Inc logo

Complete history of Mr. Tammara stock trades at Ocugen Inc

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
4 May 2021 Vijay Tammara
Vicepresidente senior
Uso de opción 15,711 $0.81 $12,726
4 May 2021
2,311
29 Apr 2021 Vijay Tammara
Vicepresidente senior
Uso de opción 34,308 $0.71 $24,359
29 Apr 2021
4,317


Ocugen Inc executives and stock owners

Ocugen Inc executives and other stock owners filed with the SEC include: